Ethionamide boosters part 2: combining bioisosteric replacement and structure-based drug design to solve pharmacokinetic issues in a series of potent 1,2,4-oxadiazole ethr inhibitors. Deposition Author(s): Baulard, A.R. , Blondiaux, N. , Brodin, P. , Christophe, T. , D Prez, B. , Desroses, M. , Flament, M.P. , Flipo, M. , Jeon, H.K. , Lecat-Guillet, N. , Leroux, F. , Locht, C. , Mathys, V. , Piveteau, C. , Siepmann, J. , Soror, S.H. , Villemagne, B. , Villeret, V. , Willand, N. , Wintjens, R. , Wohlkonig, A.
Date: 2011-06-09 Method: X-RAY DIFFRACTION Resolution: 1.87 Å Organism(s): Mycobacterium Tuberculosis Sequences Data: 3SDG_A
Ethionamide boosters part 2: combining bioisosteric replacement and structure-based drug design to solve pharmacokinetic issues in a series of potent 1,2,4-oxadiazole ethr inhibitors. Deposition Author(s): Baulard, A.R. , Blondiaux, N. , Brodin, P. , Christophe, T. , D Prez, B. , Desroses, M. , Flament, M.P. , Flipo, M. , Jeon, H.K. , Lecat-Guillet, N. , Leroux, F. , Locht, C. , Mathys, V. , Piveteau, C. , Siepmann, J. , Soror, S.H. , Villemagne, B. , Villeret, V. , Willand, N. , Wintjens, R. , Wohlkonig, A.
Date: 2011-06-13 Method: X-RAY DIFFRACTION Resolution: 2.31 Å Organism(s): Mycobacterium Tuberculosis Sequences Data: 3SFI_A